It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids ...
Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback